|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
THIRST AND VOLUME, ELECTROLYTE HOMEOSTASIS
Department of Physiology and Pharmacology, Institute of Medical Biology, University of Southern Denmark, DK-5000, Odense, Denmark
Submitted 12 May 2003 ; accepted in final form 7 July 2003
Evidence of biological activity of fragments of ANG II is accumulating. Fragments considered being inactive degradation products might mediate actions previously attributed to ANG II. The study aimed to determine whether angiotensin fragments exert biological activity when administered in amounts equimolar to physiological doses of ANG II. Cardiovascular, endocrine, and renal effects of ANG II, ANG III, ANG IV, and ANG-(1-7) (6 pmol·kg-1·min-1) were investigated in conscious dogs during acute inhibition of angiotensin I-converting enzyme (enalaprilate) and aldosterone (canrenoate). Furthermore, ANG III was investigated by step-up infusion (30 and 150 pmol·kg-1·min-1). Arterial plasma concentrations [ANG immunoreactivity (IR)] were determined by an ANG II antibody cross-reacting with ANG III and ANG IV. Metabolic clearance rates were higher for ANG III and ANG IV (391 ± 19 and 274 ± 13 ml·kg-1·min-1, respectively) than for ANG II (107 ± 13 ml·kg-1·min-1). ANG II increased ANG IR by 60 ± 7 pmol/ml, blood pressure by 30%, increased plasma aldosterone markedly (to 345 ± 72 pg/ml), and plasma vasopressin transiently, while reducing glomerular filtration rate (40 ± 2 to 33 ± 2 ml/min), sodium excretion (50 ± 7 to 16 ± 4 µmol/min), and urine flow. Equimolar amounts of ANG III induced similar antinatriuresis (57 ± 8 to 19 ± 3 µmol/min) and aldosterone secretion (to 268 ± 71 pg/ml) at much lower ANG IR increments (
1/7) without affecting blood pressure, vasopressin, or glomerular filtration rate. The effects of ANG III exhibited complex dose-response relations. ANG IV and ANG-(1-7) were ineffective. It is concluded that 1) plasma clearances of ANG III and ANG IV are higher than those of ANG II; 2) ANG III is more potent than ANG II in eliciting immediate sodium and potassium retention, as well as aldosterone secretion, particularly at low concentrations; and 3) the complexity of the ANG III dose-response relationships provides indirect evidence that several effector mechanisms are involved.
sodium excretion; antidiuresis; blood pressure; angiotensin peptides; metabolic clearance rate
This article has been cited by other articles:
![]() |
P. Bie, S. Molstrom, and S. Wamberg Normotensive sodium loading in conscious dogs: regulation of renin secretion during {beta}-receptor blockade Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2009; 296(2): R428 - R435. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Padia, B. A. Kemp, N. L. Howell, M.-C. Fournie-Zaluski, B. P. Roques, and R. M. Carey Conversion of Renal Angiotensin II to Angiotensin III Is Critical for AT2 Receptor-Mediated Natriuresis In Rats Hypertension, February 1, 2008; 51(2): 460 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kjolby and P. Bie Chronic activation of plasma renin is log-linearly related to dietary sodium and eliminates natriuresis in response to a pulse change in total body sodium Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R17 - R25. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Padia, B. A. Kemp, N. L. Howell, H. M. Siragy, M.-C. Fournie-Zaluski, B. P. Roques, and R. M. Carey Intrarenal Aminopeptidase N Inhibition Augments Natriuretic Responses to Angiotensin III in Angiotensin Type 1 Receptor-Blocked Rats Hypertension, March 1, 2007; 49(3): 625 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Giraud, J. J. Faber, S. Jonker, L. Davis, and D. F. Anderson Intravascular infusions of plasma into fetal sheep cause arterial and venous hypertension J Appl Physiol, September 1, 2005; 99(3): 884 - 889. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Kirchheim Our fragmentary knowledge of the regulatory functions of ANG II "fragments": are we beginning to see the light? Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R937 - R938. [Full Text] [PDF] |
||||
![]() |
R. R. Plovsing, C. Wamberg, N. C. F. Sandgaard, J. A. Simonsen, N.-H. Holstein-Rathlou, P. F. Hoilund-Carlsen, and P. Bie Effects of truncated angiotensins in humans after double blockade of the renin system Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R981 - R991. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |